SCHOLAR ROCK HLDG DL-001
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Its transforming growth factor beta (TGFß) superfamily biology, its novel understanding of the molecular mechanisms of growth factor activation enabled us to deve… Read more
Market Cap & Net Worth: SCHOLAR ROCK HLDG DL-001 (2QK)
SCHOLAR ROCK HLDG DL-001 (F:2QK) has a market capitalization of $3.62 Billion (€3.53 Billion) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #4155 globally and #409 in its home market, demonstrating a -9.42% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SCHOLAR ROCK HLDG DL-001's stock price €34.60 by its total outstanding shares 102007457 (102.01 Million).
SCHOLAR ROCK HLDG DL-001 Market Cap History: 2019 to 2026
SCHOLAR ROCK HLDG DL-001's market capitalization history from 2019 to 2026. Data shows growth from $1.20 Billion to $3.62 Billion (22.48% CAGR).
SCHOLAR ROCK HLDG DL-001 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SCHOLAR ROCK HLDG DL-001's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 2QK by Market Capitalization
Companies near SCHOLAR ROCK HLDG DL-001 in the global market cap rankings as of March 18, 2026.
Key companies related to SCHOLAR ROCK HLDG DL-001 by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
SCHOLAR ROCK HLDG DL-001 Historical Marketcap From 2019 to 2026
Between 2019 and today, SCHOLAR ROCK HLDG DL-001's market cap moved from $1.20 Billion to $ 3.62 Billion, with a yearly change of 22.48%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €3.62 Billion | -8.95% |
| 2025 | €3.98 Billion | -9.95% |
| 2024 | €4.42 Billion | +130.60% |
| 2023 | €1.92 Billion | +145.64% |
| 2022 | €780.07 Million | -66.44% |
| 2021 | €2.32 Billion | -41.88% |
| 2020 | €4.00 Billion | +232.17% |
| 2019 | €1.20 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of SCHOLAR ROCK HLDG DL-001 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.62 Billion USD |
| MoneyControl | $3.62 Billion USD |
| MarketWatch | $3.62 Billion USD |
| marketcap.company | $3.62 Billion USD |
| Reuters | $3.62 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.